Overview

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
To compare the renal consequences of two different approaches to blocking the renin angiotensin system in subjects with hypertension and concurrent Type II diabetes mellitus and diabetic nephropathy.
Phase:
Phase 3
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Enalapril
Enalaprilat
Telmisartan